271 Pharmacology courses in Cardiff delivered On Demand

To conduct a clinical trial in the European Economic Area under the Clinical Trials Directive the sponsor must apply for authorisation from the national competent authority (i.e. medicines regulator), and favourable opinion must be obtained from a research ethics committee, in each member state in which the trial is to take place. This module sets out the requirements for successful compilation, submission and maintenance of the applications.

Epilepsy and Buccal Midazolam Are you interested in learning about buccal midazolam for managing acute seizures in epilepsy patients? Then our epilepsy and buccal midazolam course will be your perfect guide. The principles of epilepsy, identifying various seizure types, and the pharmacology of midazolam are all covered in this course on epilepsy and buccal midazolam. This course on epilepsy and buccal midazolam also covers dose calculations and appropriate delivery methods. Additionally, safety procedures for buccal midazolam are explained in the Epilepsy and Buccal Midazolam course. This epilepsy and buccal midazolam course also explains documentation procedures, legal implications, and possible side effects. Without further delay, participate in our epilepsy and buccal midazolam course and enhance your knowledge in this field! Learning outcome of epilepsy and buccal midazolam This epilepsy and buccal midazolam course teaches: Comprehensive training on epilepsy and buccal midazolam. Handling epilepsy, emergency response, and first aid are included in this epilepsy and buccal midazolam course. This epilepsy and buccal midazolam course also explains the administration of medication. How to provide support and resources for this disorder is elaborated on in this epilepsy and buccal midazolam course. Throughout this epilepsy and buccal midazolam course, you can learn safety and lifestyle management techniques. Legal and ethical considerations are part of this epilepsy and buccal midazolam course. This epilepsy and buccal midazolam course provides simulation and case studies for practical knowledge of this field. Special Offers of this Epilepsy: Epilepsy Course This Epilepsy: Epilepsy Course includes a FREE PDF Certificate. Lifetime access to this Epilepsy: Epilepsy Course Instant access to this Epilepsy: Epilepsy Course Get FREE Tutor Support to this Epilepsy: Epilepsy Course Epilepsy and Buccal Midazolam Unlock your potential with our Epilepsy: Epilepsy and Buccal Midazolam course! Gain an in-depth understanding of Epilepsy: Epilepsy principles and learn to identify various seizure types with precision. This Epilepsy: Epilepsy course delves into the pharmacology of midazolam, ensuring accurate dose calculations and effective delivery methods. Master safety procedures for buccal midazolam in our comprehensive Epilepsy: Epilepsy training. Additionally, explore essential documentation procedures, legal implications, and potential side effects in this Epilepsy: Epilepsy course. Enroll now to enhance your expertise and provide exceptional care in the field of Epilepsy: Epilepsy management! Who is this course for? Epilepsy and Buccal Midazolam This epilepsy: epilepsy and buccal midazolam training is intended for those who work in the field of epilepsy: epilepsy care and may need to provide buccal midazolam to patients who are having seizures. Requirements Epilepsy and Buccal Midazolam To enrol in this Epilepsy: Epilepsy Course, students must fulfil the following requirements. To join in our Epilepsy: Epilepsy Course, you must have a strong command of the English language. To successfully complete our Epilepsy: Epilepsy Course, you must be vivacious and self driven. To complete our Epilepsy: Epilepsy Course, you must have a basic understanding of computers. A minimum age limit of 15 is required to enrol in this Epilepsy: Epilepsy Course. Career path Epilepsy and Buccal Midazolam With the epilepsy: epilepsy and buccal midazolam course qualification, you can work as a clinician educator, care coordinator, or epilepsy expert, with chances for research, leadership, and policy.

This module aims to provide you with effective strategies for the preparation and conduct of a clinical trial, while adhering to regulatory safety standards. Management of data for submission is also covered.

The New Drug Application (NDA) is the regulatory vehicle through which sponsors formally propose that the Food and Drug Administration (FDA) approve a new pharmaceutical for marketing and sale in the USA.

The eCTD is mandatory for all applications for marketing approval and all subsequent related submissions in the European Economic Area, the USA and Canada. Other countries intend to make its use mandatory. The eCTD specification has been developed to facilitate the global electronic submission, review and lifecycle management of medicinal product dossiers for regulatory applications. It broadens the scope of the CTD to include information on variations, renewals and amendments, so that it is no longer a static document but is updatable throughout the life of the product. This module outlines the eCTD specification, discusses the approach to regional differences in dossiers, and provides guidance on creation of an eCTD submission. The module provides a training and reference tool that will be of particular value to those new to the use of the format.

The module describes general principles of GCP inspection and audit, discusses preparation for an inspection, and sets out in detail what European and US FDA inspectors will examine. Finally it describes post-inspection actions by the regulator and the inspected party.

This module describes the design, development and installation phase, the validation phase, and the operation and maintenance phase of the validation of computerised systems in medicines and healthcare products manufacturing environments. It continues to follow the progress of a pharmaceutical company's project to validate a new dispensary control system.

In the medicines and healthcare products industries, computerised systems used in automated manufacturing or laboratory processes to which Good Manufacturing Practice requirements apply need to be validated. This module describes the planning of such validation. It follows the work of a pharmaceutical company's team as they validate the dispensary control system for a new production line.

Manufacturers of medicines and healthcare products must establish, validate and maintain an equipment cleaning programme. This is a regulatory requirement because validated cleaning procedures contribute to the assurance of product purity and safety. This module provides a comprehensive account of equipment cleaning validation requirements and procedures. It follows the work of a pharmaceutical company's validation team as they establish and validate the cleaning program for a new production line.

Essential to validation is the provision of documented evidence verifying that manufacturing processes will consistently result in products meeting predetermined quality standards. This module describes the purpose, content and use of validation master plans, project validation plans, and other documentation for validation projects in the medicines and healthcare products industries. It describes the activities of a typical validation team as they carry out a project for a pharmaceutical company.